These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34471521)

  • 1. Drafting a blueprint for the design of a rare disease ecosystem in Slovenia: Identifying salient opportunities and outlining policy recommendations.
    Stanimirovic D; Murko E; Battelino T; Groselj U; Zerjav Tansek M
    J Glob Health; 2021; 11():03064. PubMed ID: 34471521
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards a Comprehensive Strategy for the Management of Rare Diseases in Slovenia: Outlining an IT-Enabled Ecosystemic Approach.
    Stanimirovic D; Murko E; Battelino T; Groselj U; Zerjav Tansek M
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia.
    Stanimirovic D; Murko E; Battelino T; Groselj U
    Orphanet J Rare Dis; 2019 Jul; 14(1):172. PubMed ID: 31288838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charting Early Developmental Trajectory of a Pilot Rare Disease Registry in Slovenia.
    Stanimirovic D; Murko E; Battelino T; Groselj U
    Stud Health Technol Inform; 2020 Jun; 272():213-216. PubMed ID: 32604639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contradictions of public health policies geared to rare disorders: the example of the Osteogenesis Imperfecta Treatment Program in the Brazilian Unified Health System (SUS)].
    Lima MA; Horovitz DD
    Cien Saude Colet; 2014 Feb; 19(2):475-80. PubMed ID: 24863824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking the nonprofit foundation: an emerging niche in the rare disease ecosystem.
    Bakker AC; La Rosa S
    EMBO Mol Med; 2017 Sep; 9(9):1179-1182. PubMed ID: 28743783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a strategy for the management of rare diseases.
    Taylor CM; Karet Frankl FE
    BMJ; 2012 Apr; 344():e2417. PubMed ID: 22498954
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rare diseases, a public health issue].
    Donnart A; Viollet V; Roinet-Tournay M
    Soins Pediatr Pueric; 2013; (274):17-9. PubMed ID: 24228329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare diseases: what's next?
    Remuzzi G; Garattini S
    Lancet; 2008 Jun; 371(9629):1978-9. PubMed ID: 18555899
    [No Abstract]   [Full Text] [Related]  

  • 10. Restructuring public health in Slovenia between 1985 and 2006.
    Albreht T; Klazinga NS
    Int J Public Health; 2008; 53(3):150-9. PubMed ID: 19127888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 35 years of Japanese policy on rare diseases.
    Hayashi S; Umeda T
    Lancet; 2008 Sep; 372(9642):889-90. PubMed ID: 18790305
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rare diseases in Mexico].
    Rivera-Silva G; Treviño-de la Fuente F; Treviño-Alanís MG
    Rev Med Inst Mex Seguro Soc; 2018 Oct; 56(3):214-215. PubMed ID: 30365280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rare diseases as models in clinical research--from genetics to better medical care ].
    Schmidtke J; Schmidt RE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1475-6. PubMed ID: 18058147
    [No Abstract]   [Full Text] [Related]  

  • 14. Health manpower planning in Slovenia: a policy analysis of the changes in roles of stakeholders and methodologies.
    Albreht T; Klazinga N
    J Health Polit Policy Law; 2002 Dec; 27(6):1001-22. PubMed ID: 12556025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reviewing estimates of the burden in disability-adjusted life years (DALYs) of tick-borne encephalitis in Slovenia.
    Šmit R
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):299-303. PubMed ID: 30686078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rarity--a separate criterion used in prioritization?].
    Heiberg A; Frich J; Røttingen JA
    Tidsskr Nor Laegeforen; 2014 Mar; 134(5):534-6. PubMed ID: 24621914
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rare diseases: "a public health priorty". Interview by Catherine Holué].
    Podeur A
    Rev Prat; 2012 Jan; 62(1):79-80. PubMed ID: 22335073
    [No Abstract]   [Full Text] [Related]  

  • 18. Electronic Certification of Death in Slovenia - System Considerations and Development Opportunities.
    Stanimirovic D
    Stud Health Technol Inform; 2016; 223():174-81. PubMed ID: 27139401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework.
    Baynam G; Bowman F; Lister K; Walker CE; Pachter N; Goldblatt J; Boycott KM; Gahl WA; Kosaki K; Adachi T; Ishii K; Mahede T; McKenzie F; Townshend S; Slee J; Kiraly-Borri C; Vasudevan A; Hawkins A; Broley S; Schofield L; Verhoef H; Groza T; Zankl A; Robinson PN; Haendel M; Brudno M; Mattick JS; Dinger ME; Roscioli T; Cowley MJ; Olry A; Hanauer M; Alkuraya FS; Taruscio D; Posada de la Paz M; Lochmüller H; Bushby K; Thompson R; Hedley V; Lasko P; Mina K; Beilby J; Tifft C; Davis M; Laing NG; Julkowska D; Le Cam Y; Terry SF; Kaufmann P; Eerola I; Norstedt I; Rath A; Suematsu M; Groft SC; Austin CP; Draghia-Akli R; Weeramanthri TS; Molster C; Dawkins HJS
    Adv Exp Med Biol; 2017; 1031():55-94. PubMed ID: 29214566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policies and actions to tackle rare diseases at European level.
    Montserrat A; Taruscio D
    Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.